PanTher Therapeutics Announces Agreement with MD Anderson Cancer Center and Appointment of Senior Clinical Advisor
PanTher Therapeutics, the biotech company developing drug-delivery platforms for unresectable, locally advanced solid tumors, today announced an agreement with The University of Texas MD Anderson Cancer Center and the appointment of a new senior clinical advisor. The collaboration will support preclinical testing of PanTher’s lead product for pancreatic cancer, PTM-101, and is intended to demonstrate readiness for future human clinical trials.
Read More about PanTher Therapeutics Announces Agreement with MD Anderson Cancer Center and Appointment of Senior Clinical Advisor
Massachusetts Life Sciences Center selects Laura Indolfi, CEO as MassNextGen Award winner
Laura Indolfi was named one of the five winners of the Massachusetts Life Sciences Center (MLSC) Initiative for Women Entrepreneurs inaugural awards to support women in early-stage life sciences companies. Lt. Governor Karyn Polito announced the 2018 winners for the MLSC Massachusetts Next Generation Initiative (MassNextGen), a competitive program to support women entrepreneurs in early-stage life sciences companies. The public-private partnership, a five-year, $1.1 million commitment, focuses on empowering women and diversity in the next generation of life sciences entrepreneurs. Five women-led companies were selected as awardees through the MassNextGen program. Awardees represent a wide range of applications to improve human health. All five companies will receive access to a network of executive coaches for a year.
Read More about Massachusetts Life Sciences Center selects Laura Indolfi, CEO as MassNextGen Award winner
CEO of PanTher Therapeutics to speak at “How to advance in Biotech”
Drug development relies on years of experience across the industry and exposure to multiple upstream and downstream elements in order to be prepared for the challenges in our unique field. If you’re a young person working in drug or device development, what are the roles that will give you a broad set of experiences to prepare you for an eventual CEO role? Join us as we will discuss what needs to be done, and where you should put your energy today to be a leader in the field tomorrow. Hear from experts across the industry, from the investors who know what they’re looking for when it comes to biotech leadership, the experienced CEO’s who know what it takes, and some of the young people on the front lines of successful biotech startups.
Read More about CEO of PanTher Therapeutics to speak at “How to advance in Biotech”
Bristol-Myers Squibb Awards PanTher with ‘Golden Ticket’ for LabCentral
Bristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launch pad for life-sciences and biotech startups, today announced that PanTher is one of the winners of Bristol-Myers Squibb’s Golden Tickets for LabCentral. As a platinum sponsor of LabCentral, Bristol-Myers Squibb can select up to two innovative life-sciences and biotech startup companies per year of active sponsorship for “Golden Tickets,” which underwrite the cost of one lab bench for one year in LabCentral’s Kendall Square facility.
Read More about Bristol-Myers Squibb Awards PanTher with ‘Golden Ticket’ for LabCentral
A Simple Piece of Plastic Could Slash Pancreatic Cancer Death Rates
The pancreas is located in the middle of a person’s belly, surrounded by other vital organs like the liver and stomach. This both makes it extremely hard for surgeons to remove the tumor and easier for it to metastasize and spread. Chemotherapy–which sends toxic drugs throughout the body to reach the tumor site–is still often the only option, and it’s not even very effective because pancreatic tumors have few blood vessels to take up the drugs. “To me, it seems very counterintuitive to have a whole body treatment to target a specific organ,” says CEO Dr. Laura Indolfi.
Read More about A Simple Piece of Plastic Could Slash Pancreatic Cancer Death Rates
How This Entrepreneur Is Revolutionizing the Way We Treat Cancer
By the time pancreatic cancer is diagnosed, the tumors often are too large to be surgically removed. Doctors use chemotherapy to try to shrink them, but because the pancreatic tumor doesn’t have that many blood vessels, the drugs don’t often reach the tumor in the desired concentration. Biomedical engineer Dr. Laura Indolfi envisions a drug-infused bandage that can be wrapped around a tumor to solve this problem. “A lot of money has been spent, and a lot of research done, to find a new powerful agent for pancreatic cancer. But there aren’t enough blood vessels inside. It’s wrong for this type of tumor. The drug will go everywhere else.”